These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1972670)

  • 1. Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells.
    Chirmule N; Kalyanaraman VS; Slade H; Oyaizu N; Pahwa S
    Clin Exp Immunol; 1990 May; 80(2):161-6. PubMed ID: 1972670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus.
    Chirmule N; Kalyanaraman VS; Oyaizu N; Slade HB; Pahwa S
    Blood; 1990 Jan; 75(1):152-9. PubMed ID: 1967213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production.
    Manca F; Seravalli E; Valle MT; Fenoglio D; Kunkl A; Li Pira G; Zolla-Pazner S; Celada F
    Int Immunol; 1993 Sep; 5(9):1109-17. PubMed ID: 7902128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional characterization of human suppressor T-cell clones: II. Activation by Mycobacterium leprae presented by HLA-DR molecules to alpha beta T-cell receptors.
    Li SG; Elferink DG; de Vries RR
    Hum Immunol; 1990 May; 28(1):11-26. PubMed ID: 1692823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.
    Hioe CE; Tuen M; Chien PC; Jones G; Ratto-Kim S; Norris PJ; Moretto WJ; Nixon DF; Gorny MK; Zolla-Pazner S
    J Virol; 2001 Nov; 75(22):10950-7. PubMed ID: 11602735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus.
    Dis Markers; 1990; 8(4):220-1. PubMed ID: 1982426
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
    Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
    Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation.
    Tuen M; Visciano ML; Chien PC; Cohen S; Chen PD; Robinson J; He Y; Pinter A; Gorny MK; Hioe CE
    Eur J Immunol; 2005 Sep; 35(9):2541-51. PubMed ID: 16106369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
    Hioe CE; Jones GJ; Rees AD; Ratto-Kim S; Birx D; Münz C; Gorny MK; Tuen M; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):893-905. PubMed ID: 10875615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
    Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
    J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4.
    Manca F; Habeshaw JA; Dalgleish AG
    Lancet; 1990 Apr; 335(8693):811-5. PubMed ID: 1690832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.
    Liegler TJ; Stites DP
    J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):340-8. PubMed ID: 7907660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA; Bennicelli J; Guerry D
    J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.
    Scardino A; Paroli M; De Petrillo G; Michel ML; Barnaba V
    Immunology; 1994 Jan; 81(1):167-70. PubMed ID: 7907575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.
    Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E
    Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
    Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
    Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing.
    Chien PC; Cohen S; Tuen M; Arthos J; Chen PD; Patel S; Hioe CE
    J Virol; 2004 Jul; 78(14):7645-52. PubMed ID: 15220439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones.
    Fidler SJ; Dorrell L; Ball S; Lombardi G; Weber J; Hawrylowicz C; Rees AD
    Immunology; 1996 Sep; 89(1):46-53. PubMed ID: 8911139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
    Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
    J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.